An improved cell-free system for picornavirus synthesis

Journal of Virological Methods

Volumn 142, Issue 1-2, 2007, Pages 182-188

  Kobayashi, Tominari ^a   Mikami, Satoshi ^a   Yokoyama, Shigeyuki ^a,b   Imataka, Hiroaki ^a  

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cell free virus synthesis; Dialysis; EMCV; Ribozyme; RNA virus; Translation

Indexed keywords

CESIUM CHLORIDE; HAMMERHEAD RIBOZYME; POLYPROTEIN; VIRUS RNA;

ARTICLE; CELL FREE SYSTEM; DIALYSIS; ENCEPHALOMYOCARDITIS VIRUS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PICORNAVIRUS; PRIORITY JOURNAL; PROTEIN PROCESSING; RNA PROCESSING; RNA SEQUENCE; RNA SYNTHESIS; RNA TRANSLATION; VIRUS TITRATION;

CELL LINE; CELL-FREE SYSTEM; DIALYSIS; ENCEPHALOMYOCARDITIS VIRUS; HELA CELLS; HUMANS; MUTATION; PROTEIN BIOSYNTHESIS; RNA, CATALYTIC; RNA, VIRAL; VIROLOGY;

ENCEPHALOMYOCARDITIS VIRUS; PICORNAVIRIDAE; RNA VIRUSES;

EID: 34247110362     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.01.026     Document Type: Article

References (18)

1. Arnold E., Luo M., Vriend G., Rossmann M.G., Palmenberg A.C., Parks G.D., Nicklin M.J., and Wimmer E. Implications of the picornavirus capsid structure for polyprotein processing. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 21-25
2. Barton D.J., and Flanegan J.B. Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C. J. Virol. 71 (1997) 8482-8489
3. Barton D.J., O'Donnell B.J., and Flanegan J.B. 5′ Cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesis. EMBO J. 20 (2001) 1439-1448
4. Fata-Hartley C.L., and Palmenberg A.C. Dipyridamole reversibly inhibits mengovirus RNA replication. J. Virol. 79 (2005) 11062-11070
5. Hahn H., and Palmenberg A.C. Mutational analysis of the encephalomyocarditis virus primary cleavage. J. Virol. 70 (1996) 6870-6875
6. Herold J., and Andino R. Poliovirus requires a precise 5′ end for efficient positive-strand RNA synthesis. J. Virol. 74 (2000) 6394-6400
7. Kawarasaki Y., Nakano H., and Yamane T. Phosphatase-immunodepleted cell-free protein synthesis system. J. Biotechnol. 61 (1998) 199-208
8. Kim R.G., and Choi C.Y. Expression-independent consumption of substrates in cell-free expression system from Escherichia coli. J. Biotechnol. 84 (2001) 27-32
9. Mikami S., Kobayashi T., Yokoyama S., and Imataka H. A hybridoma-based in vitro translation system that efficiently synthesizes glycoproteins. J. Biotechnol. 127 (2006) 65-78
10. Mikami S., Masutani M., Sonenberg N., Yokoyama S., and Imataka H. An efficient mammalian cell-free translation system supplemented with translation factors. Protein Expr. Purif. 46 (2006) 348-357
11. Molla A., Paul A.V., and Wimmer E. Cell-free, de novo synthesis of poliovirus. Science 254 (1991) 1647-1651
12. Nagashima S., Sasaki J., and Taniguchi K. The 5′-terminal region of the Aichi virus genome encodes cis-acting replication elements required for positive- and negative-strand RNA synthesis. J. Virol. 79 (2005) 6918-6931
13. Palmenberg A.C. In vitro synthesis and assembly of picornaviral capsid intermediate structures. J. Virol. 44 (1982) 900-906
14. Palmenberg A.C. Proteolytic processing of picornaviral polyprotein. Annu. Rev. Microbiol. 44 (1990) 603-623
15. Rueckert R.R., and Pallansch M.A. Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol. 78 (1981) 315-325
16. Svitkin Y.V., Hahn H., Gingras A.C., Palmenberg A.C., and Sonenberg N. Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus. J. Virol. 72 (1998) 5811-5819
17. Svitkin Y.V., Herdy B., Costa-Mattioli M., Gingras A.C., Raught B., and Sonenberg N. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation. Mol. Cell. Biol. 25 (2005) 10556-10565
18. Svitkin Y.V., and Sonenberg N. Cell-free synthesis of encephalomyocarditis virus. J. Virol. 77 (2003) 6551-6555